Quest Diagnostics, Inc. (DGX)
243.86
-0.53
(-0.22%)
USD |
NYSE |
Aug 24, 16:00
243.86
0.00 (0.00%)
After-Hours: 20:00
Quest Diagnostics Enterprise Value : 33.02B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 33.02B |
| August 20, 2026 | 32.68B |
| August 19, 2026 | 32.73B |
| August 18, 2026 | 32.13B |
| August 17, 2026 | 32.05B |
| August 14, 2026 | 31.92B |
| August 13, 2026 | 32.10B |
| August 12, 2026 | 32.29B |
| August 11, 2026 | 32.26B |
| August 10, 2026 | 32.28B |
| August 07, 2026 | 32.36B |
| August 06, 2026 | 32.38B |
| August 05, 2026 | 32.08B |
| August 04, 2026 | 31.85B |
| August 03, 2026 | 31.65B |
| July 31, 2026 | 31.77B |
| July 30, 2026 | 31.91B |
| July 29, 2026 | 32.01B |
| July 28, 2026 | 32.09B |
| July 27, 2026 | 31.64B |
| July 24, 2026 | 31.20B |
| July 23, 2026 | 31.21B |
| July 22, 2026 | 29.22B |
| July 21, 2026 | 28.89B |
| July 20, 2026 | 28.98B |
| Date | Value |
|---|---|
| July 17, 2026 | 29.31B |
| July 16, 2026 | 29.18B |
| July 15, 2026 | 28.33B |
| July 14, 2026 | 28.80B |
| July 13, 2026 | 28.95B |
| July 10, 2026 | 28.96B |
| July 09, 2026 | 29.03B |
| July 08, 2026 | 29.04B |
| July 07, 2026 | 29.50B |
| July 06, 2026 | 29.62B |
| July 02, 2026 | 29.87B |
| July 01, 2026 | 29.90B |
| June 30, 2026 | 29.45B |
| June 29, 2026 | 30.00B |
| June 26, 2026 | 29.69B |
| June 25, 2026 | 29.28B |
| June 24, 2026 | 28.94B |
| June 23, 2026 | 28.28B |
| June 22, 2026 | 27.88B |
| June 18, 2026 | 28.04B |
| June 17, 2026 | 28.34B |
| June 16, 2026 | 28.71B |
| June 15, 2026 | 28.83B |
| June 12, 2026 | 28.93B |
| June 11, 2026 | 29.02B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Labcorp Holdings, Inc. | 33.85B |
| DaVita, Inc. | 24.68B |
| OPKO Health, Inc. | 1.201B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.475B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 333.00M |
| Revenue (Quarterly) | 3.043B |
| Total Expenses (Quarterly) | 2.724B |
| EPS Diluted (Quarterly) | 2.848 |
| Gross Profit Margin (Quarterly) | 32.53% |
| Profit Margin (Quarterly) | 10.94% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 6.15% |
| Normalized Earnings Yield | 4.096 |